The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia

Digestive and Liver Disease

Volumn 41, Issue 3, 2009, Pages 179-184

  Szoke, D ^a   Molnar B ^a   Solymosi, N ^a   Sipos, F ^a   Galamb, O ^a   Gyorffy, A ^a   Tulassay, Z ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Capillary sequencing; Chip technology; Immunohistochemistry; Intestinal metaplasia; p53 gene

Indexed keywords

ARGININE; PROTEIN P53;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER INHIBITION; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA EXTRACTION; DNA MICROARRAY; DNA POLYMORPHISM; DNA SEQUENCE; EXON; GENETIC SCREENING; GENOTYPE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; PRECANCER; PROTEIN EXPRESSION; STOMACH ANTRUM; STOMACH BIOPSY;

BIOPSY; CASE-CONTROL STUDIES; CODON; DNA; ELECTROPHORESIS, CAPILLARY; EXONS; GASTRIC MUCOSA; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENES, P53; GENOTYPE; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; METAPLASIA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; SEQUENCE ANALYSIS, DNA; STOMACH; TUMOR SUPPRESSOR PROTEIN P53;

EID: 60649116938     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.04.005     Document Type: Article

References (19)

1. Leung W.K., and Sung J.J.Y. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 16 (2002) 1209-1216
2. César A.C.G., Borim A.A., Caetano A., Cury A.C., and Silva A.E. Aneuploidies, deletion, and overexpression of TP53 gene in intestinal metaplasia of patients without gastric cancer. Cancer Genet Cytogenet 153 (2004) 127-132
3. Felley-Bosco E., Weston A., Cawley H.M., Bennett W.P., and Harris C.C. Functional studies of a germ-line polymorphism at codon 47 within the P53 gene. Am J Hum Genet 53 (1993) 752-759
4. Beckman G., Birgander R., Sjalander A., Saha N., Holmberg P.A., Kivela A., et al. Is P53 polymorphism maintained by natural selection?. Hum Hered 44 (1994) 266-270
5. Vos M., Adams C.H., Victor T.C., and van Helden P.D. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet 140 (2003) 23-30
6. Felix C.A., Brown D.L., Mitsudomi T., Ikagaki N., Wong A., Wasserman R., et al. Polymorphism at codon 36 of the P53 gene. Oncogene 9 (1994) 327-328
7. Dumont P., Leu J.I.J., Pietra A.C.D., George D.L., and Murphy M. The codon 72 polymorphic variants of P53 have markedly different apoptotic potential. Nat Genet 33 (2003) 357-365
8. Xi Y.G., Ding K.Y., Su X.L., Chen D.F., You W.C., ShenY, et al. P53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions. Carcinogenesis 25 (2004) 2201-2206
9. Perez-Perez G.I., Bosques-Padilla F.J., Crosatti M.L., Tijerina-Menchaca R., and Garza-Gonzalez E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 40 (2005) 56-60
10. Keshelava N., Zuo J.J., Chen P., Waidyaratne S.N., Luna M.C., Gomer C.J., et al. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res 61 (2001) 6185-6193
11. Takahashi Y., Ishii Y., Nagata T., Ikarashi M., Ishikawa K., and Asai S. Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer. Oncology 64 (2003) 54-60
12. Everitt B., and Rabe-Hesketh S. Analyzing medical data using S-PLUS. Statistics for biology and health (2001), Springer-Verlag, New York Inc. p. 205-22
13. R Development Core Team. R: a language and environment for statistical computing (2003), R Foundation for Statistical Computing, Vienna, Austria. 3-900051-00-3
14. Unger Zs., Molnar B., Pronai L., Szaleczky E., Zágoni T., and Tulassay Zs. Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol 15 (2003) 389-393
15. Allen A.C.P., Chiafari F.A., Kandel R., and Rohan T. Additional data for oligonucleotide arrays of the p53 gene in DNA from formalin-fixed, paraffin-embedded tissue. Clin Chem 50 (2004) 2461-2462
16. Ahrendt S.A., Halachmi S., Chow J.T., Wu L., Halachmi N., Yang S.C., et al. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci USA 96 (1999) 7382-7387
17. Ahrendt S.A., Hu Y., Buta M., McDermottMP, Benoit N., Yang S.C., et al. p53 mutations an survival in stage I non-small-cell lung cancer: results of a prospective study. J Natl Cancer Inst 95 (2003) 961-970
18. Wen W.H., Bernstein L., Lescallett J., Beazer-Barclay Y., Sullivan-Halley J., White M., et al. Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis. Cancer Res 60 (2000) 2716-3322
19. Cooper M., Li S.Q., Bhardwaj T., Rohan T., and Kandel R.A. Evaluation of oligonucleotide arrays for sequencing of the p53 gene in DNA from formalin-fixed paraffin-embedded breast cancer specimens. Clin Chem 50 (2004) 500-508